OSU-ERb-12

N/A

Report date: 2025/03/20 14:43:49
NME

Base Information

Drug NameOSU-ERb-12
Drug Alias Nameestrogen receptor beta agonist (Ohio State University/University of Texas MD Anderson Cancer Center)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor beta agonists
TargetsEstrogen receptor beta
Therapy Area/IndicationsHeart FailureProstatic NeoplasmsOvarian Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesThe Ohio State UniversityThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesN/A
Active IndicationsHeart FailureProstatic NeoplasmsOvarian Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A